{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:00:29Z","timestamp":1773288029683,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T00:00:00Z","timestamp":1235347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Hepatitis C virus (HCV) infection is a serious threat to human health worldwide. In spite of the continued search for specific and effective anti\u2010HCV therapies, the rapid emergence of drug\u2010resistance variants has been hampering the development of anti\u2010HCV drugs designed to target viral enzymes. Targeting host factors has therefore emerged as an alternative strategy offering the potential to circumvent the ever\u2010present complication of drug resistance. We previously identified protein kinase C\u2010related kinase 2 (PRK2) as a cellular kinase that phosphorylates the HCV RNA\u2010dependent RNA polymerase (RdRp). Here, we report the anti\u2010HCV activity of HA1077, also known as fasudil, and Y27632, which blocks HCV RdRp phosphorylation by suppressing PRK2 activation. Treatment of a Huh7 cell line, stably expressing a genotype 1b HCV subgenomic replicon RNA, with 20\u2003\u03bc<jats:sc>m<\/jats:sc> each of HA1077 and Y27632 reduced the HCV RNA level by 55% and 30%, respectively. A combination of the inhibitors with 100 IU\/mL interferon \u03b1 (IFN\u2010\u03b1) significantly potentiated the anti\u2010HCV drug activities resulting in approximately a 2\u2010log<jats:sub>10<\/jats:sub> viral RNA reduction. We also found that IFN\u2010\u03b1 does not activate PRK2 as well as its upstream kinase PDK1 in HCV\u2010replicating cells. Furthermore, treatment of HCV\u2010infected cells with 20\u2003\u03bc<jats:sc>m<\/jats:sc> each of HA1077 and Y27632 reduced the levels of intracellular viral RNA by 70% and 92%, respectively. Taken together, the results identify PRK2 inhibitors as potential antiviral drugs that act by suppressing HCV replication via inhibition of viral RNA polymerase phosphorylation.<\/jats:p>","DOI":"10.1111\/j.1365-2893.2009.01108.x","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T01:39:53Z","timestamp":1235439593000},"page":"697-704","source":"Crossref","is-referenced-by-count":32,"title":["Suppression of hepatitis C virus replication by protein kinase C\u2010related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase"],"prefix":"10.1111","volume":"16","author":[{"given":"S.\u2010J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010M.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u2010G.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010W.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,15]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15109-4"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260703"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.1.3.423"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.67.3.1385-1395.1993"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.9.7694-7702.1999"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.12.001"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152606776056698"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.01.009"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/135965350601100702","article-title":"Resistance of hepatitis C virus to NS3\u20104A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations","volume":"11","author":"Courcambeck J","year":"2006","journal-title":"Antivir Ther"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408617200"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3510095"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.17.9204-9210.2003"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1268"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.15.11064"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2003.11.002"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb12652.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/ol052371w"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2005.25.780"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(00)00441-3"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg407"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600393200"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M909663199"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205141200"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3420287"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.05.014"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632020501600201"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2237238100"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601367"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406435200"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.547-555.2006"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.10.4871-4877.2001"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01705-06"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209205"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90545-2"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.06.003"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00191-2"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/40187"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0689"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2000.tb01018.x"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00059-3"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01647.x"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0440"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.18.9207-9217.2002"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312245200"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2009.01108.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2009.01108.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T21:08:27Z","timestamp":1696972107000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2009.01108.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,15]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1365-2893.2009.01108.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01108.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,15]]}}}